- Alogliptin benzoate. Dipeptidyl-peptidase IV (DPP IV) inhibitor, treatment of type 2 diabetes
[作者:Wang, Y; Serradell, N; Rosa, E; Bolos, J,期刊:Drugs of the Future, 页码:7-12 , 文章类型: Article,,卷期:2008年33-1]
The prevalence of type 2 diabetes is rapidly increasing and currently available medications for the treatment of type 2 diabetes are commonly associated with secondary failure. Alogliptin (SYR-322), a potent, highly s...
- Immunotoxins targeting CD22
[作者:Houben, R; Schrama, D,期刊:Drugs of the Future, 页码:91-96 , 文章类型: Article,,卷期:2008年33-1]
CAT-3888 (RFB4[dsFv]-PE38, BL22) is a recombinant immunotoxin consisting of disulfide bond-linked Fv fragments of the parental anti-CD22 monoclonal antibody RFB4 fused to PE38, a truncated form of the bacterial Pseudo...
|